Clinical Trial Update: The Metabolite Identification and Material Balance Study of SP2086 [Phase 1]

View source ↗

Summary

This update covers a Phase 1 metabolite identification and material balance study of SP2086 for Type 2 diabetes mellitus, sponsored by Jiangsu HengRui Medicine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED